logo

Hepatitis C

2nd HCV Policy Summit on the elimination of hepatitis C in Europe

Securing sustainable funding for Hepatitis C Virus elimination plans

Programme

2nd EU HCV Summit “Securing sustainable funding for HCV elimination plans”
6th June 2018 11:30 to 18:00
Steigenberger Wiltcher’s, Brussels, Belgium

11:30 - 12:00

Welcome and introduction

 

Welcome to event and scene setting

Prof. Michael P. Manns, Co-Chair, Hepatitis B&C Public Policy Association

 

“MEP Friends of the Liver Group”

Cristian-Silviu Buşoi, Member of the European Parliament TBC

 

“European Liver Patients’ Association”

Tatjana Reic, President of the European Liver Patients Association

 

“EASL’s actions to achieve HCV Elimination in Europe”

Prof Francesco Negro, Educational Councilor of European Association ofr the Study of Liver

 

“European Civil Society Forum”

Eberhard Schatz, Coordinator CORRELATION network & European Civil Society Forum 

 

12:00 - 12:25

Session 1

Chair: Prof Georgios Papatheodoridis

 

“HCV Elimination in Europe: Burden Pathways and Cost”

Homie Razavi, Managing Director,

The Centre for Disease Analysis Foundation

 

“Microelimination”

Prof Jeffrey V. Lazarus,

Associate Professor, University of Barcelona, ACHIEVE representative

 

 

12:25 - 13:00

Session 2

Elimination in Europe: Two years from WHO Strategy

Chair: Prof Gamal Esmat

 

“WHO-EURO: Progress Report”

Dr Antons Mozalevskis, Medical Officer, WHO [TBC]

 

“EMCDDA: Progress Report”

EMCDDA representative [TBC]

 

“HCV Elimination: Prospects and challenges within EU 28”
European Commission [TBC]

13:00 - 13:15

Questions and Answers

13:15 - 14:00

Lunch break

14:00 - 14:25

Keynote address

Chair: TBC

 

“Policy actions to secure long-term funding for hepatitis elimination”
George Papandreou, President, Socialist International

 14:25 - 15:15

Session 3

The cost of HCV Elimination

Chair: Prof Francesco Negro

 

“Cost of HCV elimination: Direct medical cost, patients reported outcomes and productivity loss”

Dr. Zobair Younossi, Chairman, Department of Medicine, Inova Fairfax Medical Campus

 

“Cost of screening”

Prof. Yazdan Yazdanpanah, Professor

of Medicine, Paris Diderot University

 

"Price tag for bringing hepatitis B and C services under the umbrella of Universal Health Coverage"

Dr David Tordrup ,

WHO  Consultant, WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht University

 

“Is hepatitis elimination cost saving?”

Dr. Jagpreet Chhatwal, Assistant Professor, Harvard Medical School

 

15:15 - 15:30

Questions& answers

15:30 - 15:50

Coffee Break

15:50 - 16:30

Session 4

Innovative financing

Chair: Prof Markus Peck-Radosavljevic

 

“Innovative financing of HCV Elimination”
Dr. Jagpreet Chhatwal, Assistant Professor, Harvard Medical School

 

“HCV elimination and European financial institutions”

Dr. Panagiotis Kanavos, Associate Professor, The London School of Economics and Political Science[TBC]

 

“Financing solutions for hepatitis elimination in low and middle income countries”

Homie Razavi, Managing Director,

The Centre for Disease Analysis Foundation

 

16:30 - 16:45

Questions& answers

16:45 - 17:25

Session 5

Opportunities and challenges

Chairs: TBC

 

“ACHIEVE-Association Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe”

Tatjana Reic, President of the European Liver Patients Association

 

“European Civil Society Forum”

Eberhard Schatz, Coordinator CORRELATION network & European Civil Society Forum

 

“Hepatitis C: Political leadership for elimination”

Ricardo Baptista Leite, Member of Portuguese Parliament

 

“Savings to the healthcare service of curing patients”
[TBC]

17:25 - 17:40

Questions& answers

17:40 - 18:00

Wrap-up

 

Next steps & invitation to Call to Action

Jeffrey Lazarus and

Prof. Angelos Hatzakis, Co-Chair Hepatitis B&C Public Policy Association

The 2nd high-level European Policy Summit on the elimination of the Hepatitis C Virus (HCV) in Europe is being organised by the Hepatitis B&C Public Policy Association.

The HCV Policy Summit will take place on Wednesday, 6th June 2018 from 11.30pm to 6.30pm.

The venue for the Summit is the Steigenberger Wiltcher’s Hotel, 71 Avenue Louise, 1050 Brussels. For more information about the Steigenberger Wiltcher’s Hotel please see the link Venue. This hotel is also where the Summit attendees will be accommodated.

A buffet lunch will be offered at an interval of the Summit.

Participation at the Summit is by invitation only. If you would like to attend this event, please send an email to the Summit Administrative Secretariat: Ms Ann Fox at afox@hepbcppa.org

Please note that registration for the Summit is not possible on this website.

With financial support of

Official endorsements